Evidence map›Paper›PMID 30361697›Full record

ArticleNature cell biology2018

Deregulation of CRAD-controlled cytoskeleton initiates mucinous colorectal cancer via β-catenin.

Youn-Sang Jung, Wenqi Wang, Sohee Jun, Jie Zhang, Mrinal Srivastava, Moon Jong Kim, Esther M Lien, Joan Shang, Junjie Chen, Pierre D McCrea and 2 more

Open access · greenAbstract read
In one paragraph

Article in Nature cell biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 49 citations in OpenAlex.

  1. Cell plasticity in cancer and therapy resistance.Experimental & molecular medicine · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Form and function of actin impacts actin health and aging.bioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Screening and Characterization ofAntioxidants (Basel, Switzerland) · 2023
    Article
  18. Article
  19. Wnt signaling in liver regeneration, disease, and cancer.Clinical and molecular hepatology · 2023
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Youn-Sang JungDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0002-0168-8906
Wenqi WangDepartment of Developmental and Cell Biology, University of California, Irvine, Irvine, CA, USA.ORCID http://orcid.org/0000-0003-4053-5088
Sohee JunDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jie ZhangDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mrinal SrivastavaDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Moon Jong KimDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Esther M LienDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Joan ShangDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Junjie ChenDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pierre D McCreaProgram in Genetics and Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Songlin ZhangDepartment of Pathology, The University of Texas McGovern Medical School, Houston, TX, USA.
Jae-Il ParkDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jaeil@mdanderson.org.ORCID http://orcid.org/0000-0002-0737-2654
The University of Texas MD Anderson Cancer Center · USThe University of Texas Health Science Center at Houston · USUniversity of California, Irvine · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
UNIVERSITY OF TEXAS MD ANDERSON SPORE IN OVARIAN CANCERP50CA083639 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BAST, ROBERT C · 1999 to 2015
$33.0M
PAF-Remodeled DREAM Complex in Cancer and RegenerationR01CA193297 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI PARK, JAE-IL · 2015 to 2024
$3.6M
Regulation and function of the Hippo pathway in growth controlR01GM126048 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Wenqi Wang · 2018 to 2026
$3.0M
Nuclear functions of catenin subfamiliesR01GM107079 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MCCREA, PIERRE D · 2014 to 2017
$1.8M
NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA083639NCI NIH HHS R01 CA193297NIGMS NIH HHS R01 GM107079NIGMS NIH HHS R01 GM126048
6 · The paper itself

Abstract

Epithelial integrity is maintained by the cytoskeleton and through cell adhesion. However, it is not yet known how a deregulated cytoskeleton is associated with cancer. We identified cancer-related regulator of actin dynamics (CRAD) as frequently mutated or transcriptionally downregulated in colorectal cancer. We found that CRAD stabilizes the cadherin-catenin-actin complex via capping protein inhibition. The loss of CRAD inhibits F-actin polymerization and subsequently disrupts the cadherin-catenin-actin complex, which leads to β-catenin release and Wnt signalling hyperactivation. In mice, CRAD knockout induces epithelial cell integrity loss and Wnt signalling activation, resulting in the development of intestinal mucinous adenoma. With APC mutation, CRAD knockout initiates and accelerates mucinous and invasive adenoma development in the colorectum. These results define CRAD as a tumour suppressor, the inactivation of which deregulates the cytoskeleton and hyperactivates Wnt signalling thus initiating mucinous colorectal cancer. Our study reveals the unexpected roles of an actin cytoskeletal regulator in maintaining epithelial cell integrity and suppressing tumorigenesis.

Indexed as

Gene Expression Regulation, NeoplasticAdenocarcinoma, MucinousAdenomaAlcohol OxidoreductasesAnimalsbeta CateninCell Line, TumorColorectal NeoplasmsCytoskeletonHCT116 CellsHEK293 CellsHT29 CellsHumansMice, Inbred BALB CMice, KnockoutMice, NudeAlcohol Oxidoreductasesbeta Catenincis-retinol - androgen dehydrogenaseCRACD protein, humanMicrofilament Proteins

Identifiers

PMID30361697
PMCPMC6261439
OpenAlexW2895930912

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.